-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At present, there is a large amount of evidence supporting that exercise is closely related to reducing the side effects of cancer treatment, improving the quality of life, and reducing the risk of cancer-specific and all-cause death
.
The specific components of the exercise prescription, such as the type of exercise (such as aerobic exercise or strength training), the total duration of weekly aerobic exercise (such as a few minutes per week), and exercise intensity (such as high-intensity interval training), can improve the related Cancer health results
In other populations, such as patients with metabolic diseases (such as obesity, type 2 diabetes ), the length of daily exercise may affect disease-related health outcomes, such as weight, body composition, blood sugar control, and physical function, which are also related to cancer Survival rates are related, such as obesity, weight status, poor body composition (such as higher fat mass, lower lean meat mass), poor blood sugar control, and decreased body function/human performance are not only common cancer treatment-related side effects, but also cancer survival rates Low is related
.
The fact that the duration of exercise participation affects health outcomes related to cancer survival in other clinical populations at the same time suggests that determining the optimal exercise time may enhance the current best practice of exercise prescription for cancer patients
Diabetes determining the best exercise time may enhance current best practices in exercise prescriptions for cancer patients
This study included the medical records of patients who participated in the POWER program from 2016 to 2019 and completed follow-up evaluations to monitor their progress (n=239)
.
The average age of the participants was 61.
This study included the medical records of patients who participated in the POWER program from 2016 to 2019 and completed follow-up evaluations to monitor their progress (n=239)
In breast cancer survivors, the afternoon rather than the morning or mixed time is related to the improvement of health, lower body muscle endurance and function
.
Mixed exercise time is associated with greater waist circumference increase (total sample: 3.
In breast cancer survivors, the afternoon rather than the morning or mixed time is related to the improvement of health, lower body muscle endurance and function
This study evaluated the relationship between the daily habitual exercise training time of cancer survivors and changes in related cancer health outcomes
.
In the total sample, no statistically significant relationship was observed between specific exercise time and most of the markers that improve the evaluation of physical function (such as cardiopulmonary fitness variables, upper and lower body muscle endurance, and lower body physical mechanism)
This study evaluated the relationship between the daily habitual exercise training time of cancer survivors and changes in related cancer health outcomes
In general, the daily exercise time may have different effects on the physical functions of cancer survivors
Original source:
Original source: Original source:Adriana M.
Adriana M.
Coletta,et al.
The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors.
Adriana M.
Coletta,et al.
The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors.
PLOS ONE | https://doi.
org/10.
1371/journal.
pone.
0258135 October 12, 2021
org/10.
1371/journal.
pone.
0258135 October 12, 2021 PLOS ONE | https://doi.
org/10.
1371/journal.
pone.
0258135 October 12, 2021 Leave a message here